Jun 12, 2026 · 1h 8m
Four top investors pitch their best live trades to All-In hosts
All-In's Best Ideas Pitch Competition: 4 Investors Present Their Top Trades Live
This episode provides a rare look at how elite investors pitch and defend their high-conviction ideas under intense scrutiny from experienced operators.
- 1Four elite investors present diverse high-conviction pitches spanning nuclear energy, oncology, hospitality, and decentralized physical infrastructure.
- 2The hosts rigorously cross-examine each presenter on market tailwinds, execution risks, and capital structures.
- 3The panel debates the risk-reward profile of each distinct thesis before crowning a single investment pitch champion.
Don't miss
The hosts debate the merits of all four pitches and crown the winner of the live investment competition.
The brief
Four prominent investors pitch their highest-conviction trades live to the All-In hosts, spanning diverse sectors from hospitality and nuclear energy to biotechnology and decentralized physical infrastructure.
The pitches feature Aaron Cowen making the case for MGM Resorts, Dan Dreyfus on Talen Energy, Oleg Nodelman highlighting Aktis Oncology, and Kyle Samani presenting the decentralized mapping network GEODNET.
After evaluating the financial models, market tailwinds, and execution risks of each distinct thesis, the hosts debate the merits of the trades to crown a single winner of the pitch competition.
What was said on this episode
34 statements · 28 positive · 4 negative · 1 mixed · 1 neutral
MGM’s Osaka opportunity could more than double the stock’s value
“which we think is worth will more than double the stock”
Listen at 7:28
MGM stock could triple based on Japan and Dubai opportunities
“we think the stock is a triple”
Listen at 8:56
MGM shareholders should reject Barry Diller’s tender offer
“if you own shares, don't tender them”
Listen at 9:14
MGM shares could be worth over $100 or possibly $150
“I think the stock could be easily worth over 100, could be worth 150”
Listen at 9:20
MGM is entering the favorable investment window before Osaka opens
“we're almost in that time frame, which is why we think it's opportunistically the right period of time”
Listen at 12:26
Power demand will sharply accelerate during the emerging technology cycle
“power demand is going to really start to explode”
Listen at 14:43
AI demand is unnecessary for tight power markets over the next 20 years
“We do not need AI demand to keep the power markets incredibly tight for the next 20 years”
Listen at 14:57
Talen trades near $25 billion enterprise value versus $45 billion replacement cost
“you could probably purchase this company at a $25 billion enterprise value. The replacement cost is 45 billion”
Listen at 16:14
Talen equity could more than double merely by reaching replacement cost
“the equity value just to get to replacement cost is more than a double from where it's trading today”
Listen at 16:23
Talen could generate $50 per share in annual free cash flow without operational changes
“these guys will be generating $50 a share of free cash flow per year”
Listen at 21:59
Talen is well positioned to build new power capacity for data centers
“if they get into building power plants, and right now the regulator is telling these companies to go sit in a room”
Listen at 22:45
Investors should buy Talen shares as a speculative opportunity
“go and buy the shares. It's a good speculation”
Listen at 23:14
Human ingenuity will resolve regulatory and infrastructure constraints on AI power demand
“Human ingenuity is going to win here”
Listen at 24:21
Talen’s valuation multiple should rise as its contracted revenue increases
“the more contracts, the higher the multiple, the less the lower the multiple”
Listen at 26:59
Actis’s mini-protein platform can carry any radioactive payload
“A platform that can carry any radioactive payload”
Listen at 31:52
Actis expects initial data from its Nectin4 and B7H3 programs in 2027
“publicly guided to initial clinical data in both of these lead programs in 2027”
Listen at 32:38
Radiopharmaceuticals have a competitive moat because China cannot access radioisotopes
“because the class involves radioisotopes, it's off limits to China”
Listen at 33:33
Actis could reach $10 billion valuation if one program reaches market
“We think Actis could be worth 10 billion or $200 per share if even one of their programs makes it to market”
Listen at 34:33
Investors will accumulate Actis shares ahead of first-quarter clinical data
“our expectation is that the folks will start accumulating this in the second half in anticipation of the data coming in the first quarter”
Listen at 36:40
Human lifespan in developed countries will exceed the proposed longevity threshold
“I would take the over on that”
Listen at 37:49
Caloric restriction extends lifespan according to empirical data
“one of the only things that's ever been shown in actual, actual data to extend life is caloric restriction”
Listen at 38:00
Obesity drugs produce longevity benefits through caloric restriction
“that's literally what all the obesity drugs do”
Listen at 38:05
Geodnet’s RTK network localizes positions to approximately two centimeters
“Geodnet fundamentally is a new uses a technology called RTK or real time kinematics where you can localize your location down to about 2 centimeters”
Listen at 41:26
Geodnet is currently the largest and fastest-growing RTK network
“Today, Geodnet is the world's largest RTK network in the world. And it's also the fastest growing.”
Listen at 41:55
Geodnet is likely to become a natural monopoly with the lowest cost structure
“I think the same is likely to be true here Today. Geonet is the world's largest and fastest growing network with also the lowest cost structure by a very wide margin.”
Listen at 46:10
Geodnet revenue will more than triple over the next year
“I think it's going to probably more than triple over the next 12 months”
Listen at 46:31
Investors should own Geodnet tokens rather than company equity
“You should own the token. I own a lot of token as you might imagine. I don't own any of the equity.”
Listen at 49:21
Geodnet token is substantially undervalued because of crypto-market pessimism
“It's an unbelievably cheap asset. It's just people aren't paying attention because it's crypto bear market right now.”
Listen at 50:24
Satellite-based positioning cannot compete with Geodnet on cost
“There's no chance they can compete on cost”
Listen at 52:58
Distributed AI training projects are unlikely to succeed
“I don't think any of it's going to work”
Listen at 54:16
MGM offers the best risk-reward profile among the presented trades
“from a pure risk reward perspective, I thought MGM was the best”
Listen at 58:13
Barry Diller’s bid substantially limits MGM’s downside
“Your downside is really capped because of the Barry Diller bid”
Listen at 58:18
Space-based positioning will replace RTK and GPS within the next decade
“the space thing is likely the path. It's going to replace all RTK and all GPS in the next decade”
Listen at 1:03:17
Actis and Geodnet offer extreme upside but carry substantial loss risk
“akts and God, those are like lottery tickets. Could be crazy returns. But you know, there's a. There's a big probability of a zero there”
Listen at 1:03:33
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.